Neuromodulation Market 2020 Report Covers Key Growth Factors, Global Trends, Opportunities by Regions, Industry Size and Share Forecast to 2024 -…

Posted: Published on September 26th, 2020

This post was added by Alex Diaz-Granados

Neurological diseases are frequent in older adults, affecting around 55% of people age 55 and older. They are associated with a high risk for adverse health outcomes, including mortality, disability, institutionalization, and hospitalization. Degenerative diseases, like dementia and Parkinsons disease, as well as strokes and headaches, are frequently encountered neurological diseases in elderly patients. Neuromodulation is an intracranial, electrical neuromodulation therapy that has FDA approval for the treatment for most of the neurological diseases such as bladder control, headache, tremors, chronic pain, stroke, minimally conscious state, and spinal cord injury, which are most commonly found in the elderly population. The proven efficacy and improving acceptance of this technology are expected to lead to the surge in the market demand during the forecast period.

Scope of the Report:

Neuromodulators are a subset of neurotransmitter. Unlike neurotransmitters, the release of neuromodulators occurs in a diffuse manner. This means that an entire neural tissue may be subject to the neuromodulators action due to exposure. This, in turn, can tune the neural circuitry of an entire brain region and not just that of an individual neuron.

For More Information or Query or Customization Before Buying, Visit at https://www.industryresearch.co/enquiry/pre-order-enquiry/13999749

Key Market Trends:

Spinal Cord Stimulation (SCS) Holds the Largest Market Share in the Internal Neuromodulation Type

The process of numbing/reducing chronic pain by passing continuous low voltage electric current to the spinal cord is referred to as spinal cord stimulation (SCS). The SCS devices are FDA approved and are the most widely accepted neurostimulation techniques across the world. These devices are of basic three types namely, rechargeable, conventional, and radiofrequency systems. SCS is used in neurological problems, such as nerve damage, arachnoiditis, failed-back surgery syndrome, neuropathy, complex regional pain syndrome, and neuritis. Along with the associated benefits and effectiveness, SCS also has some pitfalls, such as overstimulation, intermittent stimulation, lead dispositioning, and device malfunctioning. However, the benefits of the SCS outrank the pitfalls, thus boosting the segments growth over the forecast period.

North America Captured the Largest Market Share and is Expected to Retain its Dominance

North America dominated the overall neuromodulation market with the United States accounting as the major contributor to the market. The presence of major market players and huge pharmaceutical and biopharmaceutical industries, coupled with the rising investments in the country for the adoption of advanced technologies, is expected to boost the regional growth of the market over the forecast period. In addition, the rising concern about the prevalence of neurological disorder and other associated disorders is stimulating the need for the adoption of neuromodulation techniques. Asia-Pacific, on the other hand, is expected to grow with the fastest growth rate over the forecast period.

Neuromodulation Market Report contents include:

Purchase this Report (Price 4250 USD for single user license) https://www.industryresearch.co/purchase/13999749

Detailed TOC of Neuromodulation Market Report 2020-2024:

1 INTRODUCTION 1.1 Study Deliverables 1.2 Study Assumptions 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS 4.1 Market Overview 4.2 Market Drivers 4.2.1 Rising Prevalence of Neurological Disorders 4.2.2 Increase in the Aging Population 4.2.3 Strong Product Pipeline 4.2.4 Expanded Target Applications and New Indications 4.2.5 Growing Investments 4.3 Market Restraints 4.3.1 Inconsistent Reimbursement Policies 4.3.2 Lack of Trained Professionals 4.4 Porters Five Forces Analysis 4.4.1 Threat of New Entrants 4.4.2 Bargaining Power of Buyers/Consumers 4.4.3 Bargaining Power of Suppliers 4.4.4 Threat of Substitute Products 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION 5.1 By Technology 5.1.1 Internal Neuromodulation 5.1.1.1 Spinal Cord Stimulation (SCS) 5.1.1.2 Deep Brain Stimulation (DBS) 5.1.1.3 Vagus Nerve Stimulation (VNS) 5.1.1.4 Sacral Nerve Stimulation (SNS) 5.1.1.5 Gastric Electrical Stimulation (GES) 5.1.2 External Neuromodulation (Non-Invasive) 5.1.2.1 Transcutaneous Electrical Nerve Stimulation (TENS) 5.1.2.2 Transcranial Magnetic Stimulation (TMS) 5.1.2.3 Respiratory Electrical Stimulation (RES) 5.2 By Application 5.2.1 Parkinsons disease 5.2.2 Depression 5.2.3 Chronic Pain 5.2.4 Failed Back Surgery 5.2.5 Ischemia 5.2.6 Urine Incontinence 5.2.7 Fecal Incontinence 5.2.8 Epilepsy 5.2.9 Gastroparesis 5.2.10 Other Applications 5.3 Geography 5.3.1 North America 5.3.1.1 US 5.3.1.2 Canada 5.3.1.3 Mexico 5.3.2 Europe 5.3.2.1 Germany 5.3.2.2 UK 5.3.2.3 France 5.3.2.4 Italy 5.3.2.5 Spain 5.3.2.6 Rest of Europe 5.3.3 Asia-Pacific 5.3.3.1 China 5.3.3.2 Japan 5.3.3.3 India 5.3.3.4 Australia 5.3.3.5 South Korea 5.3.3.6 Rest of Asia-Pacific 5.3.4 Middle East & Africa 5.3.4.1 GCC 5.3.4.2 South Africa 5.3.4.3 Rest of Middle East & Africa 5.3.5 South America 5.3.5.1 Brazil 5.3.5.2 Argentina 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE 6.1 Company Profiles 6.1.1 Medtronic PLC 6.1.2 Boston Scientific Corporation 6.1.3 St. Jude Medical Inc. 6.1.4 Synapse Biomedical Inc. 6.1.5 Nevro Corporation 6.1.6 Neurosigma Inc. 6.1.7 Neuropace Inc. 6.1.8 Neuronetics Inc. 6.1.9 Cyberonics Inc. 6.1.10 BioControl Medical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

About Industry Research:

Industry Research is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market, dedicated to bringing you an ingenious concoction of data parameters.

Contact Us:

Name: Ajay More

Phone: US +14242530807/ UK +44 20 3239 8187

Email: [emailprotected]

Our Other Reports:

Healthcare 3D Printing Market, Automotive Trailers Market, Trolley Spirometer Market

Kidney Disease Drugs Market, Electronic Motor Starters Market, Benzotrifluoride Market

Casino Table Market, Robotic Polishing Machine Market, Coffee Capsule Piercing Tools Market

Methyl Methacrylate Adhesives Market, Ear Drops Market, High-Speed Data Rate Satellite Modems Market

Motorcycle Twin Cylinder Engine Market, Erbitux Market, Breathing Exercise Devices Market

Digital Remittance Market, Hard Boiled Sweets Market, Integrated Medical Computer Carts Market

The rest is here:
Neuromodulation Market 2020 Report Covers Key Growth Factors, Global Trends, Opportunities by Regions, Industry Size and Share Forecast to 2024 -...

Related Posts
This entry was posted in Spinal Cord Injury Treatment. Bookmark the permalink.

Comments are closed.